Herzogenrath, Germany

Antonio Nardi

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Ballerup, DK (2012)
  • Herzogenrath, DE (2012 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Antonio Nardi: Innovator in Medicinal Chemistry

Introduction

Antonio Nardi is a prominent inventor based in Herzogenrath, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating various diseases. With a total of 11 patents to his name, Nardi's work has the potential to impact the medical community significantly.

Latest Patents

Nardi's latest patents include a method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease using novel 2,5-substituted pyrimidines. This invention relates to unique substituted condensed pyrimidine compounds, which are designed to act as medicaments, particularly for conditions that can be treated by inhibiting the PDE4 enzyme. Another patent focuses on substituted pyrimidine compounds, emphasizing their use as medicaments for similar medical conditions.

Career Highlights

Throughout his career, Antonio Nardi has worked with notable companies such as Grünenthal GmbH. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address pressing health issues.

Collaborations

Nardi has collaborated with talented individuals in his field, including coworkers Tobias Craan and Florian Jakob. These partnerships have likely contributed to the success of his inventions and patents.

Conclusion

Antonio Nardi's work in medicinal chemistry showcases his dedication to improving healthcare through innovation. His patents reflect a commitment to developing effective treatments for challenging medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…